Efficacy and safety of semaglutide combined with metformin in treating T2DM with overweight or obesity: a systematic review and meta-analysis.
semaglutide 與 metformin 結合治療超重或肥胖的 2 型糖尿病的療效與安全性:系統性回顧與統合分析。
Am J Transl Res 2024-09-12
Efficacy and safety of oral semaglutide in type 2 diabetes mellitus: A systematic review and meta-analysis.
口服semaglutide在2型糖尿病中的療效和安全性:系統性回顧和荟萃分析。
Diabetes Res Clin Pract 2023-04-11
Liraglutide combined with metformin treatment for obese people with type 2 diabetes mellitus: a systematic review and meta-analysis.
Liraglutide 聯合二甲双胍治療肥胖型2型糖尿病患者:系統回顧與荟萃分析。
Ir J Med Sci 2023-12-17
Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials.
Semaglutide 相較於其他胰高血糖素樣肽-1受體激動劑對第2型糖尿病患者心臟代謝風險因子的影響:一項針對頭對頭、第3期隨機對照試驗的系統性回顧和荟萃分析。
J Diabetes Complications 2023-08-04
Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysis.
一周一次的Semaglutide與每日一次的Sitagliptin作為二甲双胍附加治療對2型糖尿病患者的比較療效和安全性:系統性回顧與荟萃分析。
Ann Med 2023-10-09
Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review.
10種類胰高血糖素-1受體激動劑作為二甲双胍附加治療對第2型糖尿病患者的療效和安全性比較:系統性回顧。
Front Endocrinol (Lausanne) 2023-11-06
Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis.
糖尿病患者皮下 Semaglutide 的療效和耐受性:最新系統性回顧和荟萃分析。
Diabetol Metab Syndr 2023-10-30
Efficacy and safety of semaglutide 2.4 mg for weight loss in overweight or obese adults without diabetes: An updated systematic review and meta-analysis including the 2-year STEP 5 trial.
Semaglutide 2.4 毫克用於無糖尿病的超重或肥胖成人減重的功效和安全性:包括為期 2 年的 STEP 5 試驗的更新系統性回顧和荟萃分析。
Diabetes Obes Metab 2024-02-06
A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists.
使用胰高血糖素樣肽-1受體激動劑的安全性和有效性評論與荟萃分析。
Medicina (Kaunas) 2024-03-30
Efficacy and Safety of Oral Semaglutide in the Treatment of Type 2 Diabetes: A Meta-Analysis.
口服Semaglutide在治療2型糖尿病中的療效和安全性:一項荟萃分析。
J Clin Pharmacol 2024-06-14
Efficacy and Safety of the Combination or Monotherapy With GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Type 2 Diabetes Mellitus: An update Systematic Review and Meta-analysis.
GLP-1受體激動劑和SGLT-2抑制劑在2型糖尿病中的聯合或單獨治療的功效和安全性:最新系統性回顧和荟萃分析。
Am J Med Sci 2024-07-08